|Articles|June 14, 2016
endpoint Introduces New Tool and Branding at DIA
Advertisement
San Francisco, CA - endpoint, an interactive response technology (IRT) solutions provider, introduces its new clinical supply management tool DRIVE, which enables IRT functionality for non-IRT and Investigator-Sponsored Trials (IIT). DRIVE will be unveiled at the Drug Information Association (DIA) Annual Meeting, June 26-30, in Philadelphia. DRIVE delivers the benefits of IRT supplies management to the entire development program, including early-phase non-IRT and IIT, in one system - saving sponsors and sites time, reducing waste and optimizing the supply chain. Features include:
- Sponsorwide and program-level real-time web reporting
- Tracking of bulk and serialized drug expiration
- Management of pooled supplies across non-IRT and IRT protocols
- Management of IRT country and site sourcing
- Accountability and destruction pathways support for controlled substance needs
- SaaS do-it-yourself configurable settings
- Management of protocols and distribution networks on the fly
“While individual, stand-alone IRT systems for patient and supplies management are not warranted for every study, the challenge of managing supplies across IRT and non-IRT studies, including IIT, remains a sponsor pain point. To alleviate this issue, endpoint has developed DRIVE, a dynamic, easy-to-use clinical supply management hub,” said Chuck Harris, general manager. “DRIVE reflects endpoint’s commitment to addressing our industry’s challenges with novel, SaaS-based solutions.” endpoint will also be unveiling its new brand, which showcases endpoint’s services and technology by both highlighting the company’s proven expertise and emphasizing PULSE as a reliable IRT solution. Stop by Booth 501 at DIA or
schedule a meeting
to ask about endpoint’s feature-rich supply chain and clinical management tools and see how it gets
Straight to the Point
.
About endpoint
endpoint is focused primarily on providing interactive response technology (IRT) systems and solutions that support the life sciences industry. endpoint’s proprietary IRT system configuration engine, PULSE, provides non-technical users with the necessary tools to design and deploy customized IRT solutions in just four weeks. Having a team with up to 20 years of industry experience and headquartered in San Francisco, endpoint has been developing IRT systems since 2009. See how our flexible IRT solution meets the unique needs of any clinical trial at
www.endpointclinical.com
.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- eClinical Technology: Misconceptions, Challenges, and Opportunities
September 9th 2025
- How Sponsors Can Modernize Tools to Support Physicians
September 9th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
AstraZeneca’s Tagrisso Shows Landmark Overall Survival Benefit in Non-Small Cell Lung Cancer
2
Pfizer, BioNTech’s Comirnaty Shows Strong Immune Response in Phase III Trial for COVID-19
3
Phase III EMPOWER-Lung 3 Trial Confirms Five-Year Survival Benefit With Libtayo Plus Chemotherapy in NSCLC
4
Investigational OX40-Targetting T-Cell Therapy Shows Durable Efficacy Treating Atopic Dermatitis in Phase III Trial
5